Recruiting Neuropathy Studies in Honolulu
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
The purpose of this Phase 3 study is to demonstrate the efficacy of DNTH103 as compared to placebo in participants with chronic inflammatory demyelinating polyneuropathy (CIDP)....
A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy
The purpose of this Phase 2 study is to evaluate the safety, tolerability, pharmacometrics, and efficacy of DNTH103 in participants with multifocal motor neuropathy (MMN)....
About Neuropathy Clinical Trials in Honolulu
Neuropathy refers to damage or dysfunction of peripheral nerves, causing weakness, numbness, and pain, typically in the hands and feet. Diabetes is the most common cause, but it can also result from infections, injuries, and autoimmune conditions. Treatment focuses on managing the underlying cause and pain relief.
There are currently 2 neuropathy clinical trials recruiting participants in Honolulu, HAWAII. These studies are seeking a combined 516 participants. Research is being sponsored by Dianthus Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.
Neuropathy Clinical Trials in Honolulu — FAQ
Are there neuropathy clinical trials in Honolulu?
Yes, there are 2 neuropathy clinical trials currently recruiting in Honolulu, HAWAII. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Honolulu?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Honolulu research site will contact you about next steps.
Are clinical trials in Honolulu free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Honolulu studies also compensate for your time and travel.
What neuropathy treatments are being tested?
The 2 active trials in Honolulu are testing new therapies including novel drugs, biologics, and treatment approaches for neuropathy.
Data updated March 2, 2026 from ClinicalTrials.gov